Anti Cdk6, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cdk6/product/Boster Bio
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99
1) Product Images from "Circular RNA 0000096 affects cell growth and migration in gastric cancer"
Article Title: Circular RNA 0000096 affects cell growth and migration in gastric cancer
Journal: British Journal of Cancer
Figure Legend Snippet: Expression levels of cell cycle-related and migration-related proteins in human normal gastric epithelial and human gastric cancer cell lines following knockdown of hsa_circ_0000096. Representative western blot results of cycle-related proteins cyclin D1 and CDK6 ( A , B ). Representative western blot results of migration-related proteins MMP-2 and MMP-9 ( C , D ). Data are presented as the mean±s.d., n =3. NC, negative control. * P
Techniques Used: Expressing, Migration, Western Blot, Negative Control
Figure Legend Snippet: Knockdown of hsa_circ_0000096 suppresses cell cycle-related and migration-related protein expression. The results of cell cycle-related and migration-related protein levels in xenografts nude mouse models ( A ). Representative expression levels of cyclin D1, CDK6, MMP-2 and MMP-9 ( B ). Data are presented as the mean±s.d., n =3. NC, negative control. * P
Techniques Used: Migration, Expressing, Negative Control
2) Product Images from "Combined Anti-Cancer Effects of Platycodin D and Sorafenib on Androgen-Independent and PTEN-Deficient Prostate Cancer"
Article Title: Combined Anti-Cancer Effects of Platycodin D and Sorafenib on Androgen-Independent and PTEN-Deficient Prostate Cancer
Journal: Frontiers in Oncology
Figure Legend Snippet: PD promotes the anti-tumor effects of sorafenib in PC3 cells. (A) . The effects of PD, sorafenib and PD plus sorafenib on cell viability. (B, C) . The changes in the cell membrane and nucleus after treatment with PD alone, sorafenib (Sor) alone or PD plus sorafenib. (D) . The induction of apoptosis by PD, Sor and PD + Sor. (E) . The protein expression levels of Caspase 3, C-Caspase 3, PARP and C-PARP were examined after cells were treated with 10 μM PD alone, 10 μM sorafenib alone or PD plus sorafenib for 6 h. (F) . The ability of cells to achieve colony growth was assessed after treatment with PD alone, sorafenib alone or PD plus sorafenib for 10 days. (G) . The proliferation of cells was monitored using the CFDA SE assay after treatment with PD alone, sorafenib alone or PD plus sorafenib for 5 days. (H, I) . The cell cycle distribution of PC3 cells following treatment with PD alone, sorafenib alone or PD plus sorafenib for 24 h after pre-treatment with (H) or without (I) 2 mM thymidine. (J) . Changes in the protein expression levels of CDK4, CDK6 and cyclin D1 after treatment with 5 μM PD alone, 2.5 μM sorafenib alone or PD plus sorafenib for 24 h. * p
Techniques Used: Expressing
3) Product Images from "Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/CDK6 pathway"
Article Title: Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/CDK6 pathway
Journal: Journal of Experimental & Clinical Cancer Research : CR
Figure Legend Snippet: NEAT1 regulates CDK6 through modulating miR-107. a TargetScan database predicated CDK6 as a target of miR-107. b miR-107 decreased luciferase activity of 3′UTR but not that of 3′UTR-NC and 3′UTR-MU. miR-NC indicated scramble miRNA used as the negative control for miR-107. ** P
Techniques Used: Luciferase, Activity Assay, Negative Control